Baolingbao Biology Co., Ltd. (002286.SZ) researches, develops, manufactures and sells functional sugars and related ingredients primarily from corn in China and internationally; its core products include prebiotics such as isomaltooligosaccharide, galacto-oligosaccharide, fructooligosaccharide and xylooligosaccharide; dietary fibers including polydextrose and resistant dextrin; sugar alcohols and sweeteners such as erythritol, allulose, trehalose, crystalline fructose and maltose; starch sugars comprising maltodextrin, glucose syrup, high fructose corn syrup, solid and liquid starch sugar series; and byproducts like corn steep liquor, corn gluten meal and modified starches, which serve applications in dairy, beverages, snacks, health supplements, confectionery, daily chemicals and animal nutrition. Founded in 1997 and headquartered in Yucheng, Shandong Province, China, the company, a national high-tech enterprise and manufacturing single champion, listed on the Shenzhen Stock Exchange A-shares in 2009 and operates as a global provider of functional health solutions with exports to international markets. In 2025, Baolingbao Biology won the iSEE global innovation award at Foodaily for its high-purity human milk oligosaccharide Supmos production technology and showcased products prominently at FIC 2025; the company also reported 2024 net profit exceeding CNY100 million with over 100% growth and improved gross margins.